Interleukin-3 Promotes Hemangioblast Development in Mouse Aorta-gonad-mesonephros Region
Overview
Authors
Affiliations
Background: The hemangioblast is a bi-potential precursor cell with the capacity to differentiate into hematopoietic and vascular cells. In mouse E7.0-7.5 embryos, the hemangioblast can be identified by a clonal blast colony-forming cell (BL-CFC) assay or single cell OP9 co-culture. However, the ontogeny of the hemangioblast in mid-gestation embryos is poorly defined.
Design And Methods: The BL-CFC assay and the OP9 system were combined to illustrate the hemangioblast with lymphomyeloid and vascular potential in the mouse aorta-gonad-mesonephros region. The colony-forming assay, reverse transcriptase polymerase chain reaction analysis, immunostaining and flow cytometry were used to identify the hematopoietic potential, and Matrigel- or OP9-based methods were employed to evaluate endothelial progenitor activity.
Results: Functionally, the aorta-gonad-mesonephros-derived BL-CFC produced erythroid/myeloid progenitors, CD19(+) B lymphocytes, and CD3(+)TCRbeta(+) T lymphocytes. Meanwhile, the BL-CFC-derived adherent cells generated CD31(+) tube-like structures on OP9 stromal cells, validating the endothelial progenitor potential. The aorta-gonad-mesonephros-derived hemangioblast was greatly enriched in CD31(+), endomucin(+) and CD105(+) subpopulations, which collectively pinpoints the endothelial layer as the main location. Interestingly, the BL-CFC was not detected in yolk sac, placenta, fetal liver or embryonic circulation. Screening of candidate cytokines revealed that interleukin-3 was remarkable in expanding the BL-CFC in a dose-dependent manner through the JAK2/STAT5 and MAPK/ERK pathways. Neutralizing interleukin-3 in the aorta-gonad-mesonephros region resulted in reduced numbers of BL-CFC, indicating the physiological requirement for this cytokine. Both hematopoietic and endothelial differentiation potential were significantly increased in interleukin-3-treated BL-CFC, suggesting a persistent positive influence. Intriguingly, interleukin-3 markedly amplified primitive erythroid and macrophage precursors in E7.5 embryos. Quantitative polymerase chain reaction analysis demonstrated declined Flk-1 and elevated Scl and von Willebrand factor transcription upon interleukin-3 stimulation, indicating accelerated hemangiopoiesis.
Conclusions: The hemangioblast with lymphomyeloid potential is one of the precursors of definitive hematopoiesis in the mouse aorta-gonad-mesonephros region. Interleukin-3 has a regulatory role with regards to both the number and capacity of the dual-potential hemangioblast.
Lyadova I, Gerasimova T, Nenasheva T Front Cell Dev Biol. 2021; 9:640703.
PMID: 34150747 PMC: 8207294. DOI: 10.3389/fcell.2021.640703.
Ackermann M, Haake K, Kempf H, Kaschutnig P, Weiss A, Nguyen A Haematologica. 2020; 106(5):1354-1367.
PMID: 32327499 PMC: 8094103. DOI: 10.3324/haematol.2019.228064.
Zhao Y, Zhou J, Liu D, Dong F, Cheng H, Wang W Blood. 2015; 126(21):2383-91.
PMID: 26384355 PMC: 4653766. DOI: 10.1182/blood-2015-03-633354.
Baxter E, Mirabella F, Bowers S, James S, Bonavita A, Bertrand E J Immunol. 2012; 189(9):4459-69.
PMID: 23024272 PMC: 3480713. DOI: 10.4049/jimmunol.1201915.
Choi K, Vodyanik M, Togarrati P, Suknuntha K, Kumar A, Samarjeet F Cell Rep. 2012; 2(3):553-67.
PMID: 22981233 PMC: 3462245. DOI: 10.1016/j.celrep.2012.08.002.